Drew C. Boston

Transparency will expose facts

Machines become human

Commerce becomes seamless

Disruptive forces are accelerating innovation in the Medicaid space! Forward-looking public and private sector stakeholders are leading the way, leveraging nearly $25B in new government funding to develop novel care delivery methods and models that accelerate financial, clinical, and operational outcomes in the digital age.

Today’s model of healthcare provision is becoming increasingly unsustainable. To deliver continued improvements to the world’s health, healthcare will need to be transformed, with digital playing a central role.

On-demand companies are seizing upon the proliferation of smartphones and always-on connectivity to change customer behaviors and expectations forever. These innovative, digital-first players offer more than the products and services people want. They provide closed-loop, human-to-human transactions, deliver experiences that are as seamless as they are satisfying and, most important, they offer the convenience, simplicity and immediate gratification that characterize the lifestyle that digital… Show more

On-demand companies are seizing upon the proliferation of smartphones and always-on connectivity to change customer behaviors and expectations forever. These innovative, digital-first players offer more than the products and services people want. They provide closed-loop, human-to-human transactions, deliver experiences that are as seamless as they are satisfying and, most important, they offer the convenience, simplicity and immediate gratification that characterize the lifestyle that digital consumers want to live. Show less

On-demand is in demand. Modern day consumers yearn for convenience, simplicity, and instant gratification, and a surge of digital-first companies are answering the call. Rising investment in on-demand health services reflects an appetite for change.

Clinical and consumer design principles are colliding to create a new era of digital health solutions that are elegant, intuitive, and actually drive measurable health outcomes. FDA approvals for these next-generation solutions will triple by 2018 and drive total cost savings of $50B.